US FDA approves Cytokinetics' heart disease drug

Core Insights - The U.S. Food and Drug Administration has approved Cytokinetics' drug for treating a rare heart condition [1] Company Summary - Cytokinetics has received FDA approval for its drug, which targets a specific rare heart condition [1]